|
|
|
|
|
Lease Address
|
|
Monthly Rent
(per square foot)
|
|
4714 Gettysburg Road
|
|
$
|
29.80
|
|
4716 Gettysburg Road
|
|
$
|
30.33
|
|
4718 Gettysburg Road
|
|
$
|
25.83
|
|
4720 Gettysburg Road
|
|
$
|
25.83
|
|
960 Century Drive
|
|
$
|
15.57
|
|
4732 Gettysburg Road
|
|
$
|
26.77
|
|
-
(1)
-
Monthly
base rent equal to $20.00 per square foot will commence upon occupancy of the premises by the Company.
The
leases for 4714 and 4716 Gettysburg Road generally include an operating expense allowance with the Company responsible for its pro-rata share of operating expenses in excess of such
allowance. The leases
55
Table of Contents
for
4718, 4720 and 4732 Gettysburg Road, 960 Century Drive, and 225 Grandview Avenue are "full service" leases, except that the Company pays for electricity for 4,831 square feet of space located at
4718 Gettysburg Road and known as the data center. In fiscal year 2019, the Company paid to the Ortenzio Partnerships an aggregate amount of approximately $6.4 million for office rent, various
improvements to the Corporate Office and miscellaneous expenses.
Concentra Joint Venture
As part of a reorganization of Concentra Group Holdings, LLC consummated in connection with the acquisition of all of the issued and
outstanding equity of U.S. HealthWorks, Inc. ("U.S. HealthWorks"), Concentra Group Holdings, LLC paid a distribution in respect of, and subsequently repurchased a portion of, the equity
of Concentra Group Holdings, LLC owned by a fund affiliated with our directors, Bryan C. Cressey, William H. Frist and Daniel J. Thomas, and a separate fund affiliated with
directors Russell L. Carson and Thomas A. Scully. The aggregate distribution amounts paid to those funds were approximately $0.8 million and $8.6 million, respectively, and
the purchase price paid to those funds in the repurchase was approximately $21.9 and $214.4 million, respectively. Thereafter, Concentra Group Holdings, LLC became a wholly owned
subsidiary of Concentra Group Holdings Parent, LLC by way of a merger and, in respect of the cancellation of the equity interests of Concentra Group Holdings, LLC held by those funds as
a result of such merger, Concentra Group Holdings Parent, LLC issued equity of Concentra Group Holdings Parent, LLC equal to approximately 25.6% and 2.6% of Concentra Group Holdings
Parent, LLC on a fully diluted basis, respectively, to each of these funds. Mr. Cressey currently serves on the board of directors of Concentra Group Holdings Parent, LLC.
For
more information on the U.S. HealthWorks acquisition, please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
On
January 1, 2020, Select agreed to acquire approximately 17.20% of the outstanding membership interests of Concentra Group Holdings Parent, LLC on a fully diluted basis
(the "Interest Purchase") from a fund affiliated with our directors, Bryan C. Cressey, William H. Frist and Daniel J. Thomas, a separate fund affiliated with directors Russell L. Carson and Thomas A.
Scully and a limited liability company affiliated with director Daniel J. Thomas. The aggregate purchase price paid to those affiliated entities in connection with the Interest Purchase was
approximately $29.7 million, $165.7 million and $255,167, respectively.
On
February 1, 2020, Select agreed to acquire an additional amount of approximately 1.41% of the outstanding membership interests of Concentra Group Holdings Parent, LLC on
a fully diluted basis (the "Additional Interest Purchase") from a fund affiliated with directors Russell L. Carson and Thomas A. Scully and a limited liability company affiliated with director Daniel
J. Thomas. The aggregate purchase price paid
to those affiliated entities in connection with the Additional Interest Purchase was approximately $14.9 million and $22,966, respectively.
Approval of Related Party Transactions
The Company does not have a formal written policy for review and approval of transactions required to be disclosed pursuant to
Item 404(a) of Regulation S-K. However, the Company's practice is that any such transaction must receive the prior approval of both the Audit and Compliance Committee and a majority of
the non-interested members of the Board of Directors. In addition, it is the Company's practice that, prior to any related party transaction of the type described under
"Other Arrangements with Directors and Executive OfficersLease of Office Space," an independent third-party appraisal is
obtained that supports the amount of rent that the Company is obligated to pay for such leased space. All related party lease transactions have been unanimously approved by all of the non-interested
members of the Board of Directors.
Director Independence
Director independence is discussed under the heading "Corporate Governance" of this Proxy
Statement.
56
Table of Contents
HOUSEHOLDING
Some banks, brokers and other nominee record holders may be participating in the practice of "householding" proxy statements and annual reports.
This means that only one copy of the Company's proxy statement or annual report may have been sent to multiple stockholders in your household. The Company will promptly deliver a separate copy of
either document to you if you request one by writing or calling as follows: Investor Relations, c/o Select Medical Holdings Corporation, 4714 Gettysburg Road, Mechanicsburg, Pennsylvania 17055;
Telephone: 717-972-1100; E-mail: ir@selectmedical.com. If you want to
receive separate copies of the annual report and proxy statement in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact
your bank, broker or other nominee record holder, or you may contact the Company at the above address and phone number.
OTHER BUSINESS
The Company is not aware of any other matters that will be presented for stockholder action at the Annual Meeting. If other matters are properly
introduced, the person named in the accompanying proxy will vote the shares he or she represents as recommended by the Board of Directors.
By
Order of the Board of Directors
Michael
E. Tarvin
Executive Vice President, General Counsel and Secretary
March 4,
2020
57
Table of Contents
Appendix A
SELECT MEDICAL HOLDINGS CORPORATION
2020 EQUITY INCENTIVE PLAN
Section 1. Purpose of the Plan.
The
purpose of the Select Medical Holdings Corporation 2020 Equity Incentive Plan (the "Plan") is to assist the Company and its
Subsidiaries in attracting and retaining valued Employees, Consultants and Non-Employee Directors by offering them a greater stake in the Company's success and a closer identity with it, and to
encourage ownership of the Company's shares by such Employees, Consultants and Non-Employee Directors.
Subject
to the approval of the Plan by the stockholders of the Company, the Plan will replace the Select Medical Holdings Corporation 2016 Equity Incentive Plan, as amended and/or
restated from time to time (the "2016 Equity Plan"), and from and after such stockholder approval of the Plan, no further awards will be granted under
the 2016 Equity Plan.
Section 2. Definitions.
As
used herein, the following definitions shall apply:
2.1. "Award" means the grant of Options, SARs, Restricted Stock, Restricted Stock Units, Performance Stock, Performance Stock
Units and Other Stock-Based Awards under the Plan.
2.2. "Award Agreement" means the written agreement, instrument or document evidencing an Award.
2.3. "Board" means the Board of Directors of the Company.
2.4. "Capital Stock" means: (i) in the case of a corporation, corporate stock; (ii) in the case of an
association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock; (iii) in the case of a partnership or limited
liability company, partnership interests (whether general or limited) or membership interests; and (iv) any other interest or participation that confers on a Person the right to receive a share
of the profits and losses of, or distributions of assets of, the issuing Person, but excluding from all of the foregoing any debt securities convertible into Capital Stock, whether or not such debt
securities include any right of participation with Capital Stock.
2.5. "Cause" means,
(a) if
the applicable Participant is party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary, and such term is defined
therein, "Cause" shall have the meaning provided in such agreement;
(b) if
the applicable Participant is not a party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary or if no definition
of "Cause" is set forth in the applicable employment, consulting, severance or similar agreement, "Cause" shall have the meaning provided in the applicable Award Agreement;
(c) if
neither clause (a) nor clause (b) applies, then "Cause" shall mean (i) engaging in (A) willful or gross misconduct or (B) willful
or gross neglect; (ii) failing to follow the lawful directions of superiors or the Board or the written policies and practices of the Company or any Subsidiary; (iii) the commission of a
felony or a crime involving any of the following: moral turpitude, dishonesty, breach of trust or unethical business conduct; or the commission of any crime involving the Company or any Subsidiary;
(iv) fraud, misappropriation or embezzlement; (v) a material breach of the Participant's employment or service agreement (if any) with the Company or any Subsidiary, whether or not such
breach results in the termination of the Participant's employment or other service; (vi) acts or omissions constituting a material failure to perform substantially and adequately the duties
assigned to the Participant that are consistent with his or her position(s); (vii) any illegal act detrimental to the Company or any Subsidiary; (viii) repeated failure
A-1
Table of Contents
to
devote substantially all of the Participant's business time and efforts to the Company or any Subsidiary if required by the Participant's employment or service agreement; or (ix) the
Participant's abuse of illegal drugs or other controlled substances or the Participant's habitual intoxication while providing services to the Company or any Subsidiary.
2.6. "Change in Control" means, unless otherwise provided in an Award Agreement, after the Effective Date:
(a) the
acquisition in one or more transactions (whether by purchase, merger, amalgamation or otherwise) by any "Person" (as such term is used for purposes of
Section 13(d) or Section 14(d) of the Exchange Act, but excluding, for this purpose, (i) the Company and the Subsidiaries, (ii) any employee benefit plan of the Company or
any Subsidiary, (iii) any Permitted Holder, and (iv) an entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership
of shares of the Company) of "Beneficial Ownership" (within the meaning of Rule 13d-3 under the Exchange Act), of more than fifty percent (50%) of the combined voting power of the Company's
then outstanding voting securities (the "Voting Securities");
(b) a
change in the composition of the Board such that the individuals who as of any date constitute the Board (the "Incumbent
Board") cease to constitute a majority of the Board at any time during the 24-month period immediately following such date; provided, however, that if the election, or
nomination for election by the Company's stockholders, of any new director was approved by a vote of at least a majority of the
Incumbent Board, such new director shall be considered as a member of the Incumbent Board, and provided further that any reductions in the size of the Board that are instituted voluntarily by the
Incumbent Board shall not constitute a Change in Control, and after any such reduction the "Incumbent Board" shall mean the Board as so reduced;
(c) a
complete liquidation or dissolution or winding up of the Company (other than pursuant to a transaction in which the assets of the Company are distributed to an entity
owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of shares of the Company); or
(d) the
sale, directly or indirectly, of all or substantially all of the Company's assets (determined on a consolidated basis), other than to a Person described in
clauses (i), (ii), (iii) or (iv) of Section 2.6(a) above.
Notwithstanding
the foregoing, a restructuring, reorganization or similar or analogous event in which the stockholders of the Company immediately before such event have "Beneficial Ownership" (within
the meaning of Rule 13d-3 under the Exchange Act) of the Company, or of the resulting entity, immediately after such event in substantially the same proportions as their ownership of Shares of
the Company immediately before such event shall not constitute a Change in Control.
2.7. "Code" means the Internal Revenue Code of 1986, as amended.
2.8. "Company" means Select Medical Holdings Corporation, a Delaware corporation, or any successor corporation or company.
2.9. "Committee" means the Compensation Committee of the Board, provided that the Committee shall at all times have at least
two members, each of whom shall be a "non-employee director" as defined in Rule 16b-3 under the Exchange Act and an "independent director" under the rules of any applicable stock exchange.
2.10. "Consultant" means a natural person (within the meaning of Form S-8 of the Securities Act) who provides bona
fide services to the Company or any Subsidiary other than in connection with the offer or sale of Shares or other securities or shares in a capital-raising transaction and is not engaged in activities
that directly or indirectly promote or maintain a market for the Shares or other securities of the Company.
A-2
Table of Contents
2.11. "Disability" means,
(a) if
the applicable Participant is party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary, and such term is defined
therein, "Disability" shall have the meaning provided in such agreement;
(b) if
the applicable Participant is not a party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary or if no definition
of "Disability" is set forth in the applicable employment, consulting, severance or similar agreement, "Disability" shall have the meaning provided in the applicable Award Agreement;
(c) if
neither clause (a) nor clause (b) applies, then "Disability" shall mean that the Participant is unable to engage in any substantial gainful activity by
reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than
12 months.
2.12. "Effective Date" means the date that the Plan is approved by the stockholders of the Company.
2.13. "Employee" means an officer or other employee of the Company or a Subsidiary, including without limitation a director
who is such an employee.
2.14. "Exchange Act" means the Securities Exchange Act of 1934, as amended.
2.15. "Fair Market Value" means, on any given date (i) if the Shares are listed on any established stock exchange or a
national market system, including without limitation the New York Stock Exchange ("NYSE"), the closing sales price for such Shares as quoted on such exchange or system on the day of determination, as
reported in The Wall Street Journal or such other source as the Committee deems reliable (or, if no closing sales price was reported on that date, on
the last trading date such closing sales price was reported); (ii) if clause (i) does not apply, then if the Shares are regularly quoted by a recognized securities dealer but selling
prices are not reported, the mean between the high bid and low asked prices for the Shares on the day of determination (or, if no bids and asks were reported on that date, on the last trading date
such bids and asks were reported); or (iii) if neither clause (i) nor clause (ii) applies, such value as the Committee in its discretion may in good faith determine in accordance
with Section 409A of the Code and the regulations thereunder (and, with respect to Incentive Stock Options, in accordance with Section 422 of the Code and the regulations thereunder).
2.16. "Incentive Stock Option" means an Option or portion thereof intended to meet the requirements of an incentive stock
option as defined in Section 422 of the Code and designated as an Incentive Stock Option, and which in fact meets such requirements of Section 422 of the Code.
2.17. "Incumbent Director" means a director who either (1) is a member of the Board as of the Effective Date or
(2) is elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination.
2.18. "Non-Employee Director" means a member of the Board or a member of the board of directors of a Subsidiary, in any case,
who is not an Employee.
2.19. "Non-Qualified Option" means an Option or portion thereof that is designated as not being an Incentive Stock Option or
that does not otherwise qualify as an Incentive Stock Option.
2.20. "Option" means a right granted under Section 6.1 of the Plan to purchase a specified number of Shares at a
specified price. An Option may be an Incentive Stock Option or a Non-Qualified Option; provided, however, that unless otherwise explicitly stated in an Award Agreement, each Option is hereby
designated as a Non-Qualified Option.
2.21. "Other Stock-Based Award" means a right granted under Section 6.7 of the Plan.
2.22. "Participant" means any Employee, Non-Employee Director or Consultant who receives an Award.
A-3
Table of Contents
2.23. "Performance Goals" means any goals established by the Committee in its sole discretion upon which the vesting, earning
and/or settlement of any Award may be conditioned. Performance Goals may be described in terms of Company-wide objectives or objectives that are related to the performance of the individual
Participant or a Subsidiary, division, department or function within the Company or a Subsidiary. Performance Goals may be measured on an absolute or relative basis. Relative performance may be
measured, for example, by a group of peer companies or by a financial market index. Performance Goals may include, but are not limited to: specified levels of or increases in return on capital, equity
or assets; earnings measures/ratios (on a gross, net, pre-tax or post-tax basis), including without limitation diluted earnings per share, total earnings, operating earnings, earnings growth, earnings
before interest and taxes (EBIT) and earnings before interest, taxes, depreciation and amortization (EBITDA); revenue or revenue growth; net economic profit (which is operating earnings minus a charge
to capital); net income; operating income; sales; sales growth; gross margin; direct margin; share price (including but not limited to growth measures and total stockholder return), operating profit;
per period or cumulative cash flow (including but not limited to operating cash flow and free cash flow) or cash flow return on investment (which equals net cash flow divided by total capital);
inventory turns; financial return ratios; balance sheet measurements such as receivable turnover; improvement in or attainment of expense levels; improvement in or attainment of working capital
levels; debt reduction; strategic innovation, including but not limited to entering into, substantially completing, or receiving payments under, relating to, or deriving from a joint development
agreement, licensing agreement, or similar agreement; customer or employee satisfaction; individual objectives; operating efficiency; implementation or completion of critical projects or related
milestones; partnering or similar transactions; and any combination of any of the foregoing criteria. If the Committee determines that a change in the business, operations, corporate structure or
capital structure of the Company or a Subsidiary, or the manner in which it conducts its business, or other events or circumstances render the Performance Goals unsuitable, the Committee may modify
such Performance Goals and/or the related minimum, target, maximum and/or other acceptable levels of achievement, in whole or in part, as the Committee deems appropriate and equitable.
2.24. "Performance Period" means the period selected by the Committee during which performance is measured for the purpose of
determining the extent to which a Performance Goal has been achieved, provided that the Performance Period shall not be less than one year.
2.25. "Performance Stock" means Shares awarded by the Committee under Section 6.6 of the Plan that are subject to
Performance Goals.
2.26. "Performance Stock Unit" means the right granted under Section 6.5 of the Plan to receive, on the date of
settlement, one Share or an amount equal to the Fair Market Value of one Share, which right is subject to Performance Goals. Performance Stock Units may be settled in cash, Shares or any combination
thereof; provided, however, that unless otherwise provided in an Award Agreement, Performance Stock Units shall be settled in Shares.
2.27. "Permitted Holder" means (i) Rocco A. Ortenzio or Robert A. Ortenzio; (ii) any group (within the meaning
of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or any successor provision) of which any of the Persons referred to in clause (i) is a member; (iii) the
spouses, ancestors, siblings, descendants (including children or grandchildren by adoption) and the descendants of the siblings of the Persons referred to in clause (i); (iv) in the
event of the incompetence or death of any of the Persons described in clauses (i) or (iii), such Person's estate, executor, administrator, committee or other personal representative, in each
case, who at any particular date shall be the Beneficial Owner (within the meaning of Rule 13d-3 under the Exchange Act) or have the right to acquire, directly or indirectly, Capital Stock of
Select Medical Corporation ("Select") or the Company (or any other direct or indirect parent company of Select); (v) any trust created for the
benefit of the Persons described in any of clauses (i), (iii) or (iv) or any trust for the benefit of any such trust; or (vi) any Person controlled by any of the Persons
described in any of clauses (i) through (v).
2.28. "Person" means an individual, corporation, partnership, association, limited liability company, estate or other entity.
A-4
Table of Contents
2.29. "Prior Plans" means the Select Medical Holdings Corporation 2005 Equity Incentive Plan (as amended and/or restated from
time to time), the Select Medical Holdings Corporation 2005 Equity Incentive Plan for Non-Employee Directors (as amended and/or restated from time to time), the Select Medical Holdings Corporation
2011 Equity Incentive Plan (as amended and/or restated from time to time) and the Select Medical Holdings Corporation 2016 Equity Incentive Plan (as amended and/or restated from time to time).
2.30. "Restricted Stock" means a Share awarded by the Committee under Section 6.3 of the Plan.
2.31. "Restricted Stock Unit" means the right granted under Section 6.4 of the Plan to receive, on the date of
settlement, one Share or an amount equal to the Fair Market Value of one Share. An Award of Restricted Stock Units may be settled in cash, Shares or any combination of the foregoing; provided,
however, that unless otherwise provided in an Award Agreement, Restricted Stock Units shall be settled in Shares.
2.32. "Restriction Period" means the period during which Performance Stock, Performance Stock Units, Restricted Stock and
Restricted Stock Units are subject to forfeiture.
2.33. "SAR" means a stock appreciation right awarded by the Committee under Section 6.2 of the Plan.
2.34. "Securities Act" means the Securities Act of 1933, as amended.
2.35. "Share" means one share of the Company's common stock, par value $0.001 per share.
2.36. "Subsidiary" means any corporation, partnership, joint venture, company or other business entity of which 50% or more
of the outstanding voting power is beneficially owned, directly or indirectly, by the Company.
2.37. "Ten Percent Stockholder" means a Person who on any given date owns, either directly or indirectly (taking into account
the attribution rules contained in Section 424(d) of the Code), shares possessing more than 10% of the total combined voting power of all classes of shares of the Company or a Subsidiary.
Section 3. Eligibility.
Any
Employee, Non-Employee Director or Consultant shall be eligible to be selected to receive an Award under the Plan, as determined in the sole discretion of the Committee; provided,
however, that only persons who are Employees that are employed by the Company or a Subsidiary that qualifies as a "subsidiary corporation" of the Company under Section 424(f) of the Code may be
granted Incentive Stock Options.
Section 4. Administration and Implementation of the Plan.
4.1. The
Plan and all Award Agreements shall be administered by the Committee. Any action of the Committee in administering the Plan and an Award Agreement shall be final,
conclusive and binding on all Persons, including without limitation the Company, its Subsidiaries, Participants, Persons claiming rights from or through Participants and stockholders of the Company.
No member of the Committee (or any person to whom the Committee has delegated authority to act under the Plan) shall be personally liable for any action, determination, or interpretation taken or made
in good faith by the Committee (or such person) with respect to the Plan or any Awards granted hereunder, and all members of the Committee (and such persons to whom the Committee has delegated
authority to act under the Plan) shall be fully indemnified and protected by the Company in respect of any such action, determination or interpretation to the fullest extent permitted by law.
4.2. Subject
to the provisions of the Plan, the Committee shall have full and final authority in its discretion to (i) select the Employees, Non-Employee Directors
and Consultants who will receive Awards pursuant to the Plan; provided that Awards granted to non-employee members of the Board shall be subject to ratification by the full Board;
(ii) determine the type or types of Awards to be granted to each Participant; (iii) determine the number of Shares to which an Award will relate, the terms and conditions of any Award
granted under the Plan (including, but not limited to, restrictions as to vesting, Performance Goals relating to an Award, transferability or forfeiture, exercisability or settlement of an Award,
waivers or accelerations
A-5
Table of Contents
thereof,
and waivers of or modifications to Performance Goals relating to an Award, based in each case on such considerations as the Committee shall determine) and all other matters to be determined
in connection with an Award; (iv) determine the exercise price or purchase price (if any) of an Award; (v) determine whether, to what extent, and under what circumstances an Award may be
cancelled, forfeited, or surrendered; (vi) determine whether (and, if necessary, certify that) Performance Goals to which an Award is subject are satisfied; (vii) determine whether
Participants will be permitted to defer the settlement of certain Awards; (viii) correct any defect or supply any omission or reconcile any inconsistency in the Plan and Award Agreements, and
adopt, amend and rescind such rules, regulations, guidelines, forms of agreements and instruments relating to the Plan and Award Agreements as it may deem necessary or advisable; (ix) construe
and interpret the Plan and Award Agreements; and (x) make all other determinations as it may deem necessary or advisable for the administration of the Plan and Award Agreements. Notwithstanding
anything in the Plan or an Award Agreement to the contrary, no Option or SAR may be repriced, replaced or regranted through cancellation, nor may any underwater Option or underwater SAR be repurchased
for cash or exchanged for another Award, in any case, without the approval of the stockholders of the Company, provided that nothing herein shall prevent the Committee from taking any action provided
for in Sections 7 or 8 (with no stockholder approval required for any action permitted by Sections 7 or 8).
4.3. To
the extent permitted by applicable law and the Company's by-laws, the Committee may delegate some or all of its authority with respect to the Plan and Awards to any
executive officer of the Company or any other person or persons designated by the Committee, in each case, acting individually or as a committee, provided that the Committee may not delegate its
authority hereunder to any person to make Awards to (a) Employees who are (i) subject to the requirements of Rule 16b-3 of the Exchange Act or (ii) officers or other
Employees who are delegated authority by the Committee pursuant to this Section 4.3 or (b) members of the Board. Any delegation hereunder shall be subject to the restrictions and limits
that the Committee specifies at the time of such delegation or thereafter in its sole discretion. The Committee may at any time rescind the authority delegated to any person pursuant to this
Section 4.3. Any action undertaken by any such person or persons in accordance with the Committee's delegation of authority pursuant to this Section 4.3 shall have the same force and
effect as if undertaken directly by the Committee.
4.4. Notwithstanding
any other provision to the contrary, Awards granted to non-employee members of the Board shall be administered by the full Board, and any authority
reserved under the Plan for the Committee with regard to Awards granted to non-employee members of the Board shall be exercised by the full Board.
Section 5. Shares Subject to the Plan.
5.1. Subject
to adjustment as provided in Section 8 hereof and this Section 5, not more than 7,400,000 Shares may be delivered, in the aggregate, pursuant to
the Plan on or after the Effective Date with respect to Awards (the "Share Reserve"). The Share Reserve shall be (i) reduced by the number of
awards granted under the 2016 Equity Plan from January 1, 2020 until the Effective Date and (ii) increased by the number of Shares underlying the portion of an award granted under the
Prior Plans that is cancelled, terminated, forfeited or lapses on or after January 1, 2020 without the issuance of Shares. No more than 7,400,000 Shares issued under the Plan may be issued
pursuant to the exercise of Incentive Stock Options. The Shares issued under the Plan may, at the election of the Board, be (i) authorized but previously unissued Shares or (ii) Shares
previously issued and outstanding and reacquired by the Company. No individual shall be eligible to receive, in any one calendar year, Awards with respect to more than 2,000,000 Shares (subject to
adjustment as provided in Section 8 hereof). Notwithstanding the foregoing, Shares issued under Awards granted in assumption, substitution or exchange for previously granted awards of a company
acquired by the Company or any Subsidiary ("Substitute Awards") shall not reduce the Shares available under the Plan, and to the extent permitted by the
rules of the stock exchange on which the Shares are then listed or quoted, shares under a stockholder approved plan of an acquired company (adjusted to reflect the transaction) may be used for Awards
under the Plan and do not reduce the Share Reserve. No Non-Employee Director who is a member of the Board may be granted Awards covering more than 50,000 Shares in any one calendar year.
5.2. If
any Shares subject to an Award under the Plan are forfeited or such Award otherwise terminates for any reason whatsoever without an actual distribution of Shares to
the Participant, any Shares counted against the number of Shares available for issuance pursuant to the Plan with respect to such Award shall, to
A-6
Table of Contents
the
extent of any such forfeiture or termination, be added back to the Share Reserve and shall again be available for Awards under the Plan; provided, however, that the Committee may adopt procedures
for the counting of Shares relating to any Award to ensure appropriate counting, avoid double counting, provide for adjustments in any case in which the number of Shares actually distributed differs
from the number of Shares previously counted in connection with such Award, and if necessary, to comply with applicable law or regulations. In addition, and notwithstanding anything contained herein
to the contrary, Shares tendered in payment of the exercise price or withholding taxes with respect to an Award or any award granted under the Prior Plans shall not become, or again be, available for
Awards under the Plan.
Section 6. Awards.
Awards
may be granted on the terms and conditions set forth in this Section 6. In addition, the Committee may impose on any Award or the settlement or exercise thereof, at the
date of grant or thereafter, such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including without limitation terms requiring
forfeiture of Awards in the event of a termination of the Participant's employment or other relationship with the Company or any Subsidiary; provided, however, that the Committee shall retain full
power to accelerate or waive any such additional term or condition as it may have previously imposed (provided that, in any case, any such action is permitted under Code Section 409A). The
right of a Participant to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such Performance Goals as may be determined by the Committee. Each Award,
and the terms and conditions applicable thereto, shall be evidenced by an Award Agreement.
6.1. Options. Options give a Participant the right to purchase a specified number of Shares from the Company for
a specified time period at a fixed exercise price, as provided in the applicable Award Agreement. Options may be either Incentive Stock Options or Non-Qualified Options; provided that Incentive Stock
Options may be granted only to Employees of the Company or a "subsidiary corporation" (within the meaning of Section 424(f) of the Code) of the Company. The grant of Options shall be subject to
the following terms and conditions:
(a) Exercise Price. The price per Share at which Shares may be purchased upon exercise of an Option shall be
determined by the Committee and specified in the Award Agreement, but shall be not less than the Fair Market Value of one Share on the date of grant (or 110% of the Fair Market Value of one Share on
the date of grant in the case of an Incentive Stock Option granted to a Ten Percent Stockholder).
(b) Term of Options. The term of an Option shall be specified in the Award Agreement, but shall in no event be
greater than ten years from the grant date (or five years from the grant date in the case of an Incentive Stock Option granted to a Ten Percent Stockholder).
(c) Exercise of Option. Each Award Agreement with respect to an Option shall specify the time or times at which
an Option may be exercised in whole or in part and the terms and conditions applicable thereto,
including without limitation (i) a vesting schedule which may be based upon the passage of time, attainment of Performance Goals or a combination thereof, (ii) whether the exercise price
for an Option shall be paid in cash, with Shares, with any combination of cash and Shares, or with other legal consideration that the Committee may deem appropriate and to the extent permitted by
applicable law, (iii) the methods of payment, which may include payment through cashless and net exercise arrangements, to the extent permitted by applicable law and (iv) the methods by
which, or the time or times at which, Shares will be delivered or deemed to be delivered to Participants upon the exercise of such Option. Payment of the exercise price shall in all events be made
within three days after the date of exercise of an Option. With respect to any Participant who is subject to Section 16 of the Exchange Act, as a method of paying the exercise price of an
Option, such Participant may direct the Company to reduce the number of Shares that would otherwise be deliverable upon the exercise of such Option by the number of Shares having a Fair Market Value
on the date of exercise equal to the exercise price of the portion of the Option then being exercised.
(d) Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement or an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, and except as otherwise provided in Section 7.2 hereof, upon a termination of the
A-7
Table of Contents
Participant's
employment or other service with the Company and the Subsidiaries for any reason other than for Cause, the unvested portion of such Participant's Options shall cease to vest and shall be
forfeited (with no compensation or other payment due to the Participant or any other Person) and the vested portion of such Participant's Options shall remain exercisable by the Participant or the
Participant's beneficiary or legal representative, as the case may be, for a period of (i) 90 days in the event of a termination by the Company or a Subsidiary without Cause,
(ii) one year in the event of a termination due to death or Disability and (iii) 90 days in the event of the Participant's resignation; provided, however, that in no event shall
any Option be exercisable after its stated term has expired. Upon a termination of a Participant's employment or other service by the Company or a Subsidiary for Cause, all of such Participant's
Options, including those that are vested, shall be immediately forfeited (with no compensation or other payment due to the Participant or any other Person).
(e) Incentive Stock Options. Each Participant awarded an Incentive Stock Option under the Plan shall notify the
Company in writing immediately after the date he or she makes a "disqualifying disposition" (as defined in Section 421(b) of the Code) of any Shares acquired pursuant to the exercise of such
Incentive Stock Option. The Company may, if determined by the Committee and in accordance with procedures established by it, retain possession of any Shares acquired pursuant to the exercise of an
Incentive Stock Option as agent for the applicable Participant until the end of any period during which a disqualifying disposition could occur, subject to complying with any instructions from such
Participant as to the sale of such Shares. The aggregate Fair Market Value, determined as of the date of grant, for Awards granted under the Plan (or any other stock or share option plan required to
be taken into account under Section 422(d) of the Code) that are intended to be Incentive Stock Options which are first exercisable by the Participant during any calendar year shall not exceed
$100,000. To the extent an Award purporting to be an Incentive Stock Option exceeds
the limitation in the previous sentence or does not otherwise qualify as an Incentive Stock Option, the portion of the Award in excess of such limit or that does not so qualify shall be a
Non-Qualified Option.
(f) No Dividend Equivalent Rights. No Participant shall be entitled to dividend equivalent rights or payments
with respect to any Shares underlying the Participant's Options.
6.2. Stock Appreciation Rights. A SAR shall confer on the Participant a right to receive, upon exercise thereof,
the excess of (i) the Fair Market Value of one Share on the date of exercise over (ii) the grant price of the SAR as determined by the Committee, but which may never be less than the
Fair Market Value of one Share on the date of grant. No payment from the Participant shall be required to exercise a SAR. The grant of SARs shall be subject to the following terms and conditions:
(a) General. Each Award Agreement with respect to a SAR shall specify the number of SARs granted, the grant
price of the SAR, the time or times at which the SAR may be exercised in whole or in part (including without limitation vesting upon the passage of time, the attainment of Performance Goals or a
combination thereof), the method of exercise, the method of settlement (in cash, Shares or a combination thereof), the method by which Shares will be delivered or deemed to be delivered to
Participants (if applicable) and any other terms and conditions of the SAR.
(b) Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement or an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, and except as otherwise provided in Section 7.2 hereof, upon a termination of the Participant's
employment or other service with the Company and the Subsidiaries for any reason other than for Cause, the unvested portion of such Participant's SARs shall cease to vest and shall be forfeited (with
no compensation or other payment due to the Participant or any other Person) and the vested portion of such Participant's SARs shall remain exercisable by the Participant or the Participant's
beneficiary or legal representative, as the case may be, for a period of (i) 90 days in the event of a termination by the Company or a Subsidiary without Cause, (ii) one year in
the event of a termination due to death or Disability and (iii) 90 days in the event of the Participant's resignation; provided, however, that in no event shall any SAR be exercisable
after its stated term has expired. Upon a termination of a Participant's employment or other service by the Company or a Subsidiary for Cause, all of such Participant's SARs, including those that are
vested, shall be immediately forfeited (with no compensation or other payment due to the Participant or any other Person).
A-8
Table of Contents
(c) Term. The term of a SAR shall be specified in the Award Agreement, but shall in no event be greater than ten
years from the grant date.
(d) No Dividend Equivalent Rights. No Participant shall be entitled to dividend equivalent rights or payments
with respect to any Shares underlying the Participant's SARs.
6.3. Restricted Stock. An Award of Restricted Stock is a grant by the Company of a specified number of Shares to
the Participant, which Shares are subject to forfeiture upon the happening of specified events during the Restriction Period. Such an Award shall be subject to the following terms and conditions:
(a) General. Each Award Agreement with respect to Restricted Stock shall specify the duration of the Restriction
Period and/or each installment thereof, the conditions under which the Restricted Stock may be forfeited to the Company, and the amount, if any, the Participant must pay to receive the Restricted
Stock. Such restrictions may include a vesting schedule based upon the passage of time.
(b) Transferability. During the Restriction Period, the transferability of Restricted Stock shall be prohibited
or restricted in the manner and to the extent prescribed in the applicable Award Agreement. Such restrictions may include, without limitation, rights of repurchase or first refusal in the Company or
provisions subjecting the Restricted Stock to a continuing substantial risk of forfeiture in the hands of any transferee.
(c) Stockholder Rights. Unless otherwise provided in the applicable Award Agreement, during the Restriction
Period the Participant shall have all the rights of a stockholder with respect to Restricted Stock, including, without limitation, the right to receive dividends thereon (whether in cash or Shares)
and to vote such Shares of Restricted Stock in accordance with the Company's by-laws. Dividends may, in the discretion of the Committee, be paid currently or subject to the same restrictions as the
underlying Restricted Stock (and the Committee may, in its sole discretion, withhold any cash dividends paid on Restricted Stock until the restrictions applicable to such Restricted Stock have
lapsed); provided, however, that dividends paid on unvested Restricted Stock that is subject to Performance Goals shall not be paid or released unless and until the applicable Performance Goals have
been achieved.
(d) Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement or an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, and except as otherwise provided in Section 7.2 hereof, upon a termination of the Participant's
employment or other service with the Company and the Subsidiaries for any reason, the unvested portion of each Award of Restricted Stock granted to such Participant shall be forfeited with no
compensation or other payment due to the Participant or any other Person.
(e) Additional Matters. Upon the Award of Restricted Stock, the Committee may direct the number of Shares
subject to such Award be issued to the Participant or placed in a restricted stock account (including without limitation an electronic account) with the transfer agent and in either case designating
the Participant as the registered owner. The certificate(s), if any, representing such Shares shall be physically or electronically legended, as applicable, as to sale, transfer, assignment, pledge or
other encumbrances during the Restriction Period and, if issued to the Participant, returned to the Company to be held in escrow during the Restriction Period. In all cases, the Participant shall sign
a stock power or share transfer form (as appropriate) endorsed in blank to the Company to be held in escrow during the Restriction Period.
6.4. Restricted Stock Units. Restricted Stock Units are solely a device for the measurement and determination of
the amounts to be paid to a Participant under the Plan. Restricted Stock Units do not constitute Shares and shall not be treated as (or as giving rise to) property or as a trust fund of any kind;
provided, however,
that the Company may establish a bookkeeping reserve to meet its obligations hereunder or a trust or other funding vehicle that would not cause the Plan to be deemed to be funded for tax purposes or
for purposes of Title I of the Employee Retirement Income Security Act of 1974, as amended. The right of any Participant in respect of an Award of Restricted Stock Units shall be no greater than the
right of any unsecured general creditor of the Company. The grant of Restricted Stock Units shall be subject to the following terms and conditions:
A-9
Table of Contents
(a) Restriction Period. Each Award Agreement with respect to Restricted Stock Units shall specify the duration
of the Restriction Period, if any, and/or each installment thereof and the conditions under which such Award may be forfeited to the Company. Such restrictions may include a vesting schedule based
upon the passage of time.
(b) Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement or an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, and except as otherwise provided in Section 7.2 hereof, upon a termination of the Participant's
employment or other service with the Company and the Subsidiaries for any reason, the unvested portion of each Award of Restricted Stock Units credited to such Participant shall be forfeited with no
compensation or other payment due to the Participant or any other Person.
(c) Settlement. Unless otherwise provided in an Award Agreement, (i) an Award of Restricted Stock Units
shall be settled in Shares, provided that any fractional Restricted Stock Units shall be settled in cash and (ii) subject to the Participant's continued employment or other service with the
Company or a Subsidiary from the date of grant through the expiration of the Restriction Period (or applicable portion thereof), the vested portion of an Award of Restricted Stock Units shall be
settled within 60 days after the expiration of the Restriction Period (or applicable portion thereof).
(d) Stockholder Rights. Nothing contained in the Plan shall be construed to give any Participant rights as a
stockholder with respect to an Award of Restricted Stock Units (including, without limitation, any voting, dividend or derivative or other similar rights). Notwithstanding the foregoing, the Committee
may provide in an Award Agreement that amounts equal to any dividends declared during the Restriction Period or deferral period on the Shares represented by an Award of Restricted Stock Units will be
credited to the Participant's account and settled in Shares at the same time (and subject to the same forfeiture restrictions) as the Restricted Stock Units to which such dividend equivalents relate
(with the number of Shares released in payment of such dividend equivalents to equal the amount of dividend equivalents then being settled, divided by the Fair Market Value of one Share on the
settlement date of such dividend equivalents).
6.5. Performance Stock Units. Performance Stock Units are solely a device for the measurement and determination
of the amounts to be paid to a Participant under the Plan. Performance Stock Units do not constitute Shares and shall not be treated as (or as giving rise to) property or as a trust fund of any kind;
provided, however, that the Company may establish a bookkeeping reserve to meet its obligations hereunder
or a trust or other funding vehicle that would not cause the Plan to be deemed to be funded for tax purposes or for purposes of Title I of the Employee Retirement Income Security Act of 1974, as
amended. The right of any Participant in respect of an Award of Performance Stock Units shall be no greater than the right of any unsecured general creditor of the Company. The grant of Performance
Stock Units shall be subject to the following terms and conditions:
(a) Restriction Period. Each Award Agreement with respect to Performance Stock Units shall specify the duration
of the Performance Period and the Restriction Period, if any, and/or each installment thereof, the Performance Goals applicable to the Performance Stock Units and the conditions under which the
Performance Stock Units may be forfeited to the Company. Such restrictions shall include a vesting schedule based on the attainment of one or more Performance Goals.
(b) Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement or an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, and except as otherwise provided in Section 7.2 hereof, upon a termination of the Participant's
employment or other service with the Company and the Subsidiaries for any reason, the unvested portion of each Award of Performance Stock Units credited to such Participant shall be forfeited with no
compensation or other payment due to the Participant or any other Person.
(c) Settlement. Unless otherwise provided in an Award Agreement, (i) an Award of Performance Stock Units
shall be settled in Shares, provided that any fractional Performance Stock Units shall be settled in cash and (ii) subject to the Participant's continued employment or other service with the
Company or a Subsidiary from the grant date through the expiration of the Restriction Period (or applicable portion thereof), the vested portion of an Award of Performance Stock Units shall be settled
within 60 days after the expiration of the Restriction Period (or applicable portion thereof).
A-10
Table of Contents
(d) Stockholder Rights. Nothing contained in the Plan shall be construed to give any Participant rights as a
stockholder with respect to an Award of Performance Stock Units (including, without limitation, any voting, dividend or derivative or other similar rights). Notwithstanding the foregoing, the
Committee may provide in an Award Agreement that amounts equal to any dividends declared by the Company during the Restriction Period on the Shares represented by an Award of Performance Stock Units
will be credited to the Participant's account and settled in cash or Shares at the same or a different time (and subject to the same or different or no forfeiture restrictions, but always subject to
the same Performance Goals) as the Performance Stock Units to which such dividend equivalents relate (with the number of Shares released in payment of such dividend equivalents to equal the amount of
dividend equivalents then being settled, divided by the Fair Market Value of one Share on the settlement date of such dividend equivalents).
6.6. Performance Stock. An Award of Performance Stock is a grant by the Company of a specified number of Shares
to the Participant, which Shares are conditional on the achievement of Performance Goals during the
Performance Period and subject to forfeiture upon the happening of specified events during the Restriction Period. An Award of Performance Stock shall be subject to the following terms and conditions.
(a) General. Each Award Agreement with respect to Performance Stock shall specify the duration of the
Performance Period and the Restriction Period, if any, and/or each installment thereof, the Performance Goals applicable to the Performance Stock and the conditions under which the Performance Stock
may be forfeited to the Company, and the amount, if any, the Participant must pay to receive the Performance Stock.
(b) Transferability. During the Restriction Period, if any, the transferability of Performance Stock shall be
prohibited or restricted in the manner and to the extent prescribed in the applicable Award Agreement. Such restrictions may include, without limitation, rights of repurchase or first refusal in the
Company or provisions subjecting the Performance Stock to a continuing substantial risk of forfeiture in the hands of any transferee.
(c) Stockholder Rights. Unless otherwise provided in the applicable Award Agreement, during the Restriction
Period the Participant shall have all the rights of a stockholder with respect to Performance Stock, including, without limitation, the right to receive dividends thereon (whether in cash or Shares),
but only to the extent that Performance Stock vests based on the achievement of Performance Goals, and to vote such shares of Performance Stock. Dividends shall be subject to the same restrictions
(and Performance Goals) as the underlying Performance Stock and the Committee shall withhold any cash dividends paid on Performance Stock until the Performance Goals are achieved and restrictions
applicable to such Performance Stock have lapsed.
(d) Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement or an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, and except as otherwise provided in Section 7.2 hereof, upon a termination of the Participant's
employment or other service with the Company and the Subsidiaries for any reason, the unvested portion of each Award of Performance Stock granted to such Participant shall be forfeited with no
compensation or other payment due to the Participant or any other Person.
6.7. Other Stock-Based Awards. The Committee is authorized, subject to limitations under applicable law, to
grant to Participants any type of Award (in addition to those Awards provided in Sections 6.1, 6.2, 6.3, 6.4, 6.5 and 6.6 hereof) that is payable in, or valued in whole or in part by reference
to, Shares, and that is deemed by the Committee to be consistent with the purposes of the Plan, including, without limitation, fully vested Shares and dividend equivalents
("Other Awards").
Section 7. Change in Control.
7.1. General. Unless otherwise provided in an Award Agreement or an effective employment, consulting, severance
or similar agreement with the Company or a Subsidiary, a Change in Control shall not, in and of itself, accelerate the vesting, settlement or exercisability of outstanding Awards. Notwithstanding the
foregoing and unless otherwise provided in an Award Agreement or an effective employment, consulting,
severance or similar agreement with the Company or a Subsidiary, if (i) the successor corporation or company (or its direct or indirect parent) does not agree to assume an outstanding Award or
does not agree
A-11
Table of Contents
to
substitute or replace such Award with an award involving the ordinary equity securities of such successor corporation or company (or its direct or indirect parent) on terms and conditions necessary
to preserve the rights of the applicable Participant with respect to such Award, (ii) the securities of the Company or the successor corporation or company (or its direct or indirect parent)
will not be publicly traded on a U.S. securities exchange immediately following such Change in Control or (iii) the Change in Control is not approved by a majority of the Incumbent Directors
immediately prior to such Change in Control, then the Committee, in its sole discretion, may take one or more of the following actions with respect to all, some or any such Awards:
(a) accelerate the vesting and, if applicable, exercisability of such Awards such that the Awards are fully vested and, if applicable, exercisable (effective immediately prior to such Change in
Control); (b) with respect to any Awards that do not constitute "non-qualified deferred compensation" within the meaning of Code Section 409A, accelerate the settlement of such Awards
upon such Change in Control; (c) with respect to Awards that constitute "non-qualified deferred compensation" within the meaning of Code Section 409A, terminate all such Awards and
settle all such Awards for a cash payment equal to the Fair Market Value of the Shares underlying such Awards less the amount the Participant is required to pay for such Shares, if any, provided that
(I) such Change in Control satisfies the requirements of Treasury Regulation Section 1.409A-3(i)(5)(v), (vi) or (vii) and (II) all other arrangements that would be
aggregated with such Awards under Code Section 409A are terminated and liquidated within 30 days before or 12 months after such Change in Control; (d) cancel outstanding
Options or SARs in exchange for a cash payment in an amount equal to the excess, if any, of the Fair Market Value of the Shares underlying the unexercised portion of the Option or SAR as of the date
of the Change in Control over the exercise price or grant price, as the case may be, of such portion, provided that any Option or SAR with a per Share exercise price or grant price, as the case may
be, that equals or exceeds the Fair Market Value of one Share on the date of the Change in Control shall be cancelled with no payment due the Participant and (e) take such other actions as the
Committee deems appropriate. If any action is taken with respect to any Award under items (a) through (e) of this Section 7.1 and such Award is subject to Performance Goals, such
Performance Goals shall be deemed satisfied based on the actual level of achievement of the applicable Performance Goals through the date of the Change in Control or, if determined by the Committee in
its sole discretion prior to such Change in Control, using the applicable target level of achievement rather than such actual level of achievement. The judgment of the Committee with respect to any
matter referred to in this Section 7.1 shall be conclusive and binding upon each Participant without the need for any amendment to the Plan or any Award or Award Agreement. Notwithstanding the
foregoing, no Award that constitutes "non-qualified deferred compensation" (within the meaning of Section 409A of the Code) shall be payable upon the occurrence of a Change in Control unless
such Change in Control satisfies the requirements of Treasury Regulation Section 1.409A-3(i)(5).
7.2. Termination Following a Change in Control. Notwithstanding anything contained in the Plan to the contrary,
unless otherwise provided in an Award Agreement or an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary, in the event that Awards under the Plan are
assumed in connection with a Change in Control or are substituted with new awards, in either case, pursuant to Section 7.1 above, and a Participant's employment or other service with the
Company or a Subsidiary is terminated by the Company or such Subsidiary without Cause or due to Disability or as the result of the Participant's death, in any case, within 24 months following a
Change in Control, then (i) the unvested portion of such Participant's Awards (including, without limitation, any awards received in substitution of an Award) shall vest in full (with any
applicable Performance Goals being deemed to have
been achieved at target or, if greater, actual levels of performance), (ii) Awards of Options and SARs (including, without limitation, options and stock or share appreciation rights received in
substitution of an Award) shall remain exercisable by the Participant or the Participant's beneficiary or legal representative, as the case may be, for a period of one year thereafter (but not beyond
the stated term of such Option or SAR or such substituted option or appreciation right), (iii) all Restricted Stock Units and Performance Stock Units (including, without limitation, restricted
stock units and performance stock units received in substitution of an Award) shall be settled within 30 days after such termination and (iv) all Other Stock-Based Awards (including,
without limitation, any received in substitution of an Award) shall be settled within 30 days after such termination; provided, however, that with respect to clauses (iii) and (iv), if
settlement of any such Award (including, without limitation, any award received in substitution of such Award) on the date described in this Section 7.2 would violate Code Section 409A,
then such Award (including, without limitation, any award received in substitution of such Award) instead shall be settled in full at the time it
A-12
Table of Contents
otherwise
would have been settled in connection with a termination of employment or service without Cause or due to death or Disability, as applicable. At the time of the grant of an Award, the
Committee may choose to not apply this Section 7.2 with respect to such Award (as set forth in the applicable Award Agreement).
Section 8. Adjustments upon Changes in Capitalization.
8.1. In
order to prevent dilution or enlargement of the rights of Participants under the Plan as a result of any dividend payable in Shares, recapitalization, forward share
split or reverse share split, reorganization, division, merger, consolidation, amalgamation, spin-off, extraordinary cash dividend or other similar or analogous corporate transaction or event that
affects the Shares, the Committee shall adjust (i) the number and/or kind of Shares which may thereafter be issued in connection with Awards, (ii) the number and/or kind of Shares
issuable in respect of outstanding Awards, (iii) the aggregate number and/or kind of Shares available under the Plan (including without limitation any of the specific limitations under
Section 5 hereof), and (iv) the exercise or grant price relating to any Award. Any such adjustment shall be made in an equitable manner which reflects the effect of such transaction or
event. It is provided, however, that in the case of any such transaction or event, the Committee may make any additional adjustments to the items in (i) through (iv) above which it deems
appropriate in the circumstances, or make provision for a cash payment with respect to any outstanding Award.
8.2. In
addition to the adjustments described in Section 8.1 above, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria
included in, Awards, including without limitation any Performance Goals, in recognition of unusual or nonrecurring events affecting the Company or any Subsidiary, or in response to changes in
applicable laws, regulations, or accounting principles (including, without limitation, (a) asset write-downs; (b) significant litigation or claim judgments or settlements; (c) the
effect of changes in tax laws, accounting standards or principles, or other laws or regulatory rules affecting reporting results; (d) any reorganization and/or restructuring programs or change
in the corporate structure or capital structure of the Company or a Subsidiary; (e) extraordinary nonrecurring items as described in management's discussion and analysis of financial condition
and results of operations appearing in the Company's annual report to stockholders for the applicable year or period; (f) acquisitions or divestitures; (g) any other specific unusual or
nonrecurring events or objectively determinable category thereof; (h) foreign exchange gains and losses; and (i) a change in the Company's fiscal year).
8.3. If
both Sections 7 and 8 could apply to a transaction or event described in Section 8.1, then Section 7 shall control.
Section 9. Termination and Amendment.
9.1. Changes to the Plan and Awards. The Board may amend, alter, suspend, discontinue, or terminate the Plan
without the consent of the Company's stockholders or Participants, except that any such amendment or alteration shall be subject to the approval of the Company's stockholders if (i) such action
would increase the number of Shares subject to the Plan (other than in connection with adjustments under Section 8.1), (ii) such action would decrease the price at which Awards may be
granted, or (iii) such stockholder approval is required by any applicable federal, state or foreign law or regulation or the rules of any stock exchange or automated quotation system on which
the Shares may then be listed or quoted, and the Board may otherwise, in its discretion, determine to submit such other changes to the Plan to the Company's stockholders for approval; provided,
however, that without the consent of an affected Participant, no amendment, alteration, suspension, discontinuation, or termination of the Plan may materially and adversely affect the rights of such
Participant under any outstanding Award unless such amendment, alteration, suspension, discontinuation or termination is required by law or the rules of any applicable securities exchange.
9.2. The
Committee may waive any condition or right under, or amend, alter, suspend, discontinue, or terminate, any Award theretofore granted and any Award Agreement
relating thereto; provided, however, that without the consent of an affected Participant, no such amendment, alteration, suspension, discontinuation or termination of any Award may materially and
adversely affect the rights of such Participant under such Award unless such amendment, alteration, suspension, discontinuation or termination is required by law or the rules of any applicable
securities exchange.
A-13
Table of Contents
9.3. Notwithstanding
anything in Section 8 or this Section 9 to the contrary, any Performance Goal applicable to an Award shall not be deemed a fixed
contractual term, but shall remain subject to adjustment by the Committee, in its discretion at any time in view of the Committee's assessment of the Company's strategy, performance of comparable
companies, and other circumstances.
9.4. For
the avoidance of doubt, any power reserved to the Committee under Section 7 or Section 8 may be taken by the Committee without the consent of any
Participant or any other Person.
9.5. No Repricing. Notwithstanding anything in the Plan or an Award Agreement to the contrary, no Option or SAR
may be repriced, replaced or regranted through cancellation, nor may any underwater Option or underwater SAR be repurchased for cash or exchanged for another Award, in any case, without the approval
of the stockholders of the Company, provided that nothing herein shall prevent the Committee from taking any action provided for in Sections 7 or 8 (with no stockholder approval required for
any action permitted by Sections 7 or 8).
Section 10. No Right to Award, Employment or Service.
No
Employee, Consultant or Non-Employee Director shall have any claim to be granted any Award under the Plan, and there is no obligation that the terms of Awards be uniform or consistent
among Participants. Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of the Company or any Subsidiary. For
purposes of the Plan, a transfer of employment or service between the Company and any Subsidiary shall not be deemed a termination of employment or service; provided, however, that individuals
employed by, or otherwise providing services to, an entity that ceases to be a Subsidiary shall be deemed to have incurred a termination of employment or service, as the case may be, as of the date
such entity ceases to be a Subsidiary unless such individual becomes an employee of, or service provider to, the Company or another Subsidiary as of the date of such cessation. A change in status from
Employee to Consultant shall be deemed to be a termination of employment, unless otherwise determined by the Committee. The Committee may adopt rules and make determinations on how a leave of absence
will impact an Award, including, without limitation, tolling the vesting schedule or treating such leave of absence as a termination of employment or other service.
Section 11. Taxes.
Each
Participant must make appropriate arrangement for the payment of any taxes relating to an Award granted hereunder. The Company or any Subsidiary is authorized to withhold from any
payment relating to an Award under the Plan, including without limitation from a distribution of Shares, amounts of withholding and other taxes due in connection with any transaction involving an
Award, and to take such other action as the Committee may deem advisable to enable the Company and Participants to satisfy obligations for the payment of withholding taxes and other tax obligations
relating to any Award (including without limitation withholding from any payroll or other payment due to a Participant). This authority shall include the ability to withhold or receive Shares or other
property and to make cash payments in respect thereof in satisfaction of a Participant's tax obligations. With respect to any Participant who is subject to Section 16 of the Exchange Act, in
order to pay the withholding taxes related to an Award, such Participant may direct the Company to reduce the number of Shares that would otherwise be deliverable upon the exercise, settlement or
vesting of such Award having a Fair Market Value on the date of exercise, settlement or vesting (as the case may be)
equal to the tax withholding due in connection with such exercise, settlement or vesting (as the case may be). Withholding of taxes in the form of Shares with respect to an Award shall not occur at a
rate that exceeds the minimum required statutory federal and state withholding rates.
Section 12. Limits on Transferability; Beneficiaries.
No
Award or other right or interest of a Participant under the Plan shall be (i) pledged, encumbered, or hypothecated to, or in favor of, or subject to any lien, obligation, or
liability of such Participant to, any party, other than the Company or any Subsidiary, or (ii) assigned or transferred by such Participant other than by will or the laws of descent and
distribution, and such Awards and rights shall be exercisable during the lifetime of the Participant only by the Participant or (with respect to Awards other than Incentive Stock Options) his or her
guardian or legal representative. Notwithstanding the foregoing, the Committee may, in its discretion, provide that Non-Qualified Options, SARs, Performance Stock and Restricted Stock be transferable,
without consideration, to immediate family members (i.e., children, grandchildren or spouse), to
A-14
Table of Contents
trusts
for the benefit of such immediate family members and to partnerships in which such family members are the only partners (any vesting conditions shall be unaffected by such transfer). The
Committee may attach to such transferability feature such terms and conditions as it deems advisable. In addition, a Participant may, in the manner established by the Committee, designate a
beneficiary (which may be a Person or a trust) to exercise the rights of the Participant, and to receive any distribution, with respect to any Award upon the death of the Participant. A beneficiary,
guardian, legal representative or other Person claiming any rights under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award Agreement
applicable to such Participant, except as otherwise determined by the Committee, and to any additional restrictions deemed necessary or appropriate by the Committee.
Section 13. Foreign Nationals.
Without
amending the Plan, Awards may be granted to Employees, Consultants and Non-Employee Directors who are foreign nationals or are employed or providing services outside the United
States or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to further the purpose of the Plan.
Moreover, the Committee may approve such supplements to, or sub-plans, amendments, restatements or alternative versions of, the Plan as it may consider necessary or appropriate for such purposes
without thereby affecting the terms of the Plan as in effect for any other purpose, provided that no such supplements, sub-plans, amendments, restatements or alternative versions shall include any
provisions that are prohibited by the terms of the Plan, as then in effect, unless the Plan could have been amended to eliminate such prohibition without further approval by the stockholders of the
Company.
Section 14. Securities Law Requirements.
14.1. No
Shares may be issued hereunder if the Company shall at any time determine that to do so would (i) violate the listing requirements of an applicable
securities or stock exchange, or adversely affect the registration or qualification of the Company's Shares under any state or federal law, or (ii) require the consent or approval of any
regulatory or supervising body or stockholders. In any of the events referred to in clause (i) or clause (ii) above, the issuance of such Shares shall be suspended and shall not be
effective unless and until such listing, registration, qualifications, consents or approval shall have been effected or obtained free of any conditions not acceptable to the Company in its sole
discretion, notwithstanding any termination of any Award or any portion of any Award during the period when issuance has been suspended (provided, however, that if permitted under Code
Section 409A, the Committee may toll the expiration date of an Award such that it will not terminate during any such period of suspension).
14.2. The
Committee may require, as a condition to the issuance of Shares hereunder, representations, warranties and agreements to the effect that such Shares are being
purchased or acquired by the Participant for investment only and without any present intention to sell or otherwise distribute such Shares, and that the Participant will not dispose of such Shares in
transactions which, in the opinion of counsel to the Company, would violate the registration provisions of the Securities Act and the rules and regulations thereunder.
Section 15. Termination.
Unless
earlier terminated, the Plan shall terminate with respect to the grant of new Awards on the earlier of the 10-year anniversary of the Effective Date or the 10-year anniversary of
the date the Plan was approved by the Board, and no Awards under the Plan shall thereafter be granted; provided that no such termination shall impact Awards that were granted prior to such
termination.
Section 16. Fractional Shares.
The
Company will not be required to issue any fractional Shares pursuant to the Plan. The Committee may provide for the elimination of fractions or settlement of such fractional Shares
in cash, in its sole discretion.
Section 17. Discretion.
In
exercising, or declining to exercise, any grant of authority or discretion hereunder, the Committee may consider or ignore such factors or circumstances and may accord such weight to
such factors and
A-15
Table of Contents
circumstances
as the Committee alone and in its sole judgment deems appropriate and without regard to the effect such exercise, or declining to exercise such grant of authority or discretion, would
have upon the affected Participant, any other Participant, any Employee, any Consultant, any Non-Employee Director, the Company, any Subsidiary, any affiliate, any stockholder or any other Person.
Section 18. Code Section 409A.
The
Plan and all Awards are intended to comply with, or be exempt from, Code Section 409A and all regulations, guidance, compliance programs and other interpretative authority
thereunder, and shall be interpreted in a manner consistent therewith. In the event that a Participant is a "specified employee" within the meaning of Code Section 409A, and a payment or
benefit provided for under the Plan would be subject to additional tax under Code Section 409A if such payment or benefit is paid within six (6) months after such Participant's
"separation from service" (within the meaning of Code Section 409A), then such payment or benefit shall not be paid (or commence) during the six (6) month period immediately following
such Participant's separation from service except as provided in the immediately following sentence. In such an event, any payments or benefits that would otherwise have been made or provided during
such six (6) month period and which would have incurred such additional tax under Code Section 409A shall instead be paid to the Participant in a lump-sum, without interest, on the
earlier of (i) the first business day of the seventh month following the month in which such Participant's separation from service occurs or (ii) the tenth business day following such
Participant's death (but not earlier than if such delay had not applied). A Participant's right to receive any installment payments under an Award Agreement, including without limitation as the result
of any deferral of an Award in accordance with Code Section 409A, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at
all times be considered a separate and distinct payment as permitted under Code Section 409A. Notwithstanding anything contained in the Plan or in an Award Agreement to the contrary, neither
the Company, any member of the Committee nor any Subsidiary shall have any liability or obligation to any Participant or any other Person for taxes, interest, penalties or fines (including without
limitation any of the foregoing resulting from the failure of any Award granted hereunder to comply with, or be exempt from, Code Section 409A). Any Award that is to be settled or paid upon a
termination of employment or service and that constitutes "non-qualified deferred compensation" under Code Section 409A shall not be paid or settled unless such termination of employment or
service constitutes a "separation from service" within the meaning of Code Section 409A.
Section 19. Governing Law.
To
the extent that federal law does not govern, the validity and construction of the Plan and all Award Agreements entered into pursuant to the Plan shall be construed and enforced in
accordance with the laws of the State of Delaware, but without giving effect to the conflict of laws principles thereof.
Section 20. Recoupment/Share Ownership.
Any
Award granted pursuant to the Plan (and all Shares acquired thereunder) shall be subject to mandatory repayment and clawback pursuant to the terms of the Company's corporate
governance guidelines, as in effect from time to time, and as may otherwise be required by law or the rules of any applicable securities exchange. Additional recoupment and clawback policies may be
provided in the Participant's Award Agreement. In addition, all Awards granted under the Plan (and all Shares acquired thereunder) shall be subject to the holding periods set forth in the Company's
stock ownership guidelines, as in effect from time to time.
Section 21. Effective Date.
The
Plan shall become effective upon the Effective Date, and no Award shall become exercisable, realizable or vested prior to the Effective Date.
[End
of Plan]
A-16
MMMMMMMMMMMM MMMMMMMMMMMMMMM SELECT MEDICAL HOLDINGS CORPORATION C123456789 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000004 ENDORSEMENT_LINE______________ SACKPACK_____________ Your vote matters heres how to vote! You may vote online or by phone instead of mailing this card. Votes submitted electronically must be MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 received by April 27, 2020 at 11:59 P.M., local time. Online GIof ntoo welwewct.reonnviicsivoontrienpgo, rts.com/SEM or delete QR code and control # scan the QR code login details are located in the shaded bar below. Phone Call toll free 1-800-652-VOTE (8683) within the USA, US territories and Canada Save paper, time and money! Sign up for electronic delivery at www.envisionreports.com/SEM Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q + 1. Election of Directors: 01 - Bryan C. Cressey For Against Abstain For Against Abstain For Against Abstain 02 - Robert A. Ortenzio 03 - Daniel J. Thomas For Against Abstain For Against Abstain 2. Non-binding advisory vote to approve executive compensation 3. Vote to approve the Select Medical Holdings Corporation 2020 Equity Incentive Plan 4. Ratification of the appointment of PriceWaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2020 NOTE: Please sign as name appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such. Date (mm/dd/yyyy) Please print date below. Signature 1 Please keep signature within the box. Signature 2 Please keep signature within the box. MMMMMMM C 1234567890 J N T 4 6 3 5 7 MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND + 1 U P X 4 036E8C MMMMMMMMM B Authorized Signatures This section must be completed for your vote to be counted. Date and Sign Below A Proposals The Board of Directors recommends a vote FOR each Board of Directors nominee, FOR the approval of the executive compensation resolution, FOR the approval of the Select Medical Holdings Corporation 2020 Equity Incentive Plan, and FOR the ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2020. Annual Meeting Proxy Card1234 5678 9012 345
Important Notice Regarding the Internet Availability of Proxy Materials for the 2020 Annual Meeting of Stockholders. The Proxy Statement and the 2019 Annual Report to Stockholders are available at: www.envisionreports.com/SEM q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q + 2020 Annual Meeting of Stockholders April 28, 2020 THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS OF THE COMPANY The undersigned hereby appoints Michael E. Tarvin and Martin F. Jackson, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the shares of Select Medical Holdings Corporation Common Stock which the undersigned is entitled to vote, and, in their discretion, to vote upon such other business as may properly come before the 2020 Annual Meeting of Stockholders of the Company to be held April 28, 2020 or at any adjournment or postponement thereof, with all powers which the undersigned would possess if present at the Annual Meeting. (Continued and to be marked, dated and signed, on the other side) Change of Address Please print new address below. Comments Please print your comments below. + C Non-Voting Items Proxy Select Medical Holdings Corporation Small steps make an impact. Help the environment by consenting to receive electronic delivery, sign up at www.envisionreports.com/SEM
MMMMMMMMMMMM SELECT MEDICAL HOLDINGS CORPORATION Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q + 1. Election of Directors: 01 - Bryan C. Cressey For Against Abstain For Against Abstain For Against Abstain 02 - Robert A. Ortenzio 03 - Daniel J. Thomas For Against Abstain For Against Abstain 2. Non-binding advisory vote to approve executive compensation 3. Vote to approve the Select Medical Holdings Corporation 2020 Equity Incentive Plan 4. Ratification of the appointment of PriceWaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2020 NOTE: Please sign as name appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such. Date (mm/dd/yyyy) Please print date below. Signature 1 Please keep signature within the box. Signature 2 Please keep signature within the box. + 1 U P X 4 4 6 3 5 7 036E9C MMMMMMMMM B Authorized Signatures This section must be completed for your vote to be counted. Date and Sign Below A Proposals The Board of Directors recommends a vote FOR each Board of Directors nominee, FOR the approval of the executive compensation resolution, FOR the approval of the Select Medical Holdings Corporation 2020 Equity Incentive Plan, and FOR the ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2020. Annual Meeting Proxy Card
Important Notice Regarding the Internet Availability of Proxy Materials for the 2020 Annual Meeting of Stockholders. The Proxy Statement and the 2019 Annual Report to Stockholders are available at: www.edocumentview.com/SEM q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q 2020 Annual Meeting of Stockholders April 28, 2020 THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS OF THE COMPANY The undersigned hereby appoints Michael E. Tarvin and Martin F. Jackson, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the shares of Select Medical Holdings Corporation Common Stock which the undersigned is entitled to vote, and, in their discretion, to vote upon such other business as may properly come before the 2020 Annual Meeting of Stockholders of the Company to be held April 28, 2020 or at any adjournment or postponement thereof, with all powers which the undersigned would possess if present at the Annual Meeting. (Continued and to be marked, dated and signed, on the other side) Proxy Select Medical Holdings Corporation